Literature DB >> 22565948

Texas legitimizes path around FDA oversight.

Laura DeFrancesco.   

Abstract

Mesh：

Year:  2012        PMID： 22565948     DOI： 10.1038/nbt0512-379

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Adult stem cell therapies walk the line.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2012-08       Impact factor: 54.908

2.  Call for fellowship programs in stem cell-based regenerative and cellular medicine: new stem cell training is essential for physicians.

Authors:  Paul S Knoepfler
Journal:  Regen Med       Date:  2013-03       Impact factor: 3.806
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.